Key statistics
On Friday, GeneDx Holdings Corp (WGS:NSQ) closed at 77.80, -12.69% below its 52-week high of 89.11, set on Oct 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 75.90 |
---|---|
High | 80.13 |
Low | 74.70 |
Bid | 77.85 |
Offer | 82.85 |
Previous close | 75.18 |
Average volume | 1.02m |
---|---|
Shares outstanding | 27.47m |
Free float | 21.48m |
P/E (TTM) | -- |
Market cap | 2.14bn USD |
EPS (TTM) | -3.17 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
- GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
- GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
- GeneDx to Participate in Upcoming Investor Conferences
- GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
- GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
- GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
- GeneDx to Participate in 44th Annual Cowen Health Care Conference
- GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
More ▼